3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Dysplasia
1
Papillomavirus Infections
1
Infections
1
Interventions
liposomal amphotericin B
2
Therapeutics
2
Itraconazole
2
Caspofungin
2
lime
1
Voriconazole
1
Valacyclovir
1
Surgical Procedures, Operative
1
Ribavirin
1
Polymerase Chain Reaction
1
Pentetic Acid
1
Palivizumab
1
Olive Oil
1
Moxifloxacin
1
Minocycline
1
Levofloxacin
1
Immunologic Techniques
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Heparin
1
Fluconazole
1
Flow Cytometry
1
ER 30346
1
Acyclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
lime
×
Gynecologic
×
Clear all
NCT02346227
2018-10-12
KINVAV
Universiteit Antwerpen
Phase 3
Completed
327 enrolled